An unknown buyer acquired certain non-core assets of Marlowe plc (AIM:MRL) for £2.3 million on January 21, 2019. The assets comprise two contracts to produce specialist chemical products with applications in healthcare and clinical disinfection. The proceeds of the sale will be used for general corporate purposes. Nicholas Wells of Cenkos Securities plc acted as financial advisor to Marlowe. An unknown buyer completed the acquisition of certain non-core assets of Marlowe plc (AIM:MRL) on January 21, 2019.